Nocardiosis (central nervous system manifestations)
Updates to Article Attributes
Central nervous system (CNS) nocardiosis is a rare infection that may affect both the brain and the spine in patients with immunodeficiency.
Epidemiology
CNS nocardiosis has been reported to represent ~2% of all cerebral abscesses, and to be present in 15-50% of patients with systemic infection 2-3.
Clinical presentation
Symptoms may vary according to the type of presentation and its extension in the CNS: headache, nausea, vomiting, focal neurological deficit and seizures are reported as the most common 2-3.
Pathology
Nocardia spp. are aerobic gram-positive bacilli which are ubiquitous saprophytic organisms 1-3. The infection is acquired primarily by inhalation of the bacillus from the environment, from where it can spread hematogenouslyhaematogenously to other organs and tissues 1-2. In the CNS the infection manifests as meningitis, granuloma with giant cells or cerebral abscesses 2.
Identification of Nocardia spp.in the clinical laboratory can be challenging: the organism may grow on cultures in intervals between 4 days to 2–4 weeks 1.
Radiographic features
This infection has no specific features to aid in suggesting the diagnosis. It typically manifests as a parenchymal abscess in any part of the brain, though spinal cord abscesses and meningitis have also been described 1,2.
Treatment and prognosis
Medical and surgical opinions should be sought 4,5. Empiric antibiotic treatment consists of trimethoprim-sulfamethoxazole plus either a carbapenem class antibiotic and/or amikacin 4, while surgical management includes craniotomy or aspiration of abscesses 4,5. Both craniotomy and aspiration have been found to be equally effective 5.
-<p><strong>Central nervous system (CNS) nocardiosis</strong> is a rare <a href="/articles/cns-infectious-diseases">infection</a> that may affect both the brain and the spine in patients with immunodeficiency. </p><h4>Epidemiology</h4><p>CNS nocardiosis has been reported to represent ~2% of all <a href="/articles/brain-abscess-1">cerebral abscesses</a>, and to be present in 15-50% of patients with systemic infection <sup>2-3</sup>. </p><h4>Clinical presentation</h4><p>Symptoms may vary according to the type of presentation and its extension in the CNS: headache, nausea, vomiting, focal neurological deficit and seizures are reported as the most common <sup>2-3</sup>. </p><h4>Pathology</h4><p><em>Nocardia </em><em>spp.</em> are aerobic gram-positive bacilli which are ubiquitous saprophytic organisms <sup>1-3</sup>. The infection is acquired primarily by inhalation of the bacillus from the environment, from where it can spread hematogenously to other organs and tissues <sup>1-2</sup>. In the CNS the infection manifests as <a href="/articles/pyogenic-meningitis">meningitis</a>, granuloma with giant cells or <a href="/articles/brain-abscess-1">cerebral abscesses</a> <sup>2</sup>. </p><p>Identification of <em>Nocardia spp. </em>in the clinical laboratory can be challenging: the organism may grow on cultures in intervals between 4 days to 2–4 weeks <sup>1</sup>.</p><h4>Radiographic features</h4><p>This infection has no specific features to aid in suggesting the diagnosis. It typically manifests as a <a href="/articles/brain-abscess-1">parenchymal abscess</a> in any part of the brain, though spinal cord abscesses and <a href="/articles/leptomeningitis">meningitis</a> have also been described <sup>1,2</sup>.</p><h4>Treatment and prognosis</h4><p>Medical and surgical opinions should be sought <sup>4,5</sup>. Empiric antibiotic treatment consists of trimethoprim-sulfamethoxazole plus either a carbapenem class antibiotic and/or amikacin <sup>4</sup>, while surgical management includes craniotomy or aspiration of abscesses <sup>4,5</sup>. Both craniotomy and aspiration have been found to be equally effective <sup>5</sup>.</p>- +<p><strong>Central nervous system (CNS) nocardiosis</strong> is a rare <a href="/articles/cns-infectious-diseases">infection</a> that may affect both the brain and the spine in patients with immunodeficiency. </p><h4>Epidemiology</h4><p>CNS nocardiosis has been reported to represent ~2% of all <a href="/articles/brain-abscess-1">cerebral abscesses</a>, and to be present in 15-50% of patients with systemic infection <sup>2-3</sup>. </p><h4>Clinical presentation</h4><p>Symptoms may vary according to the type of presentation and its extension in the CNS: headache, nausea, vomiting, focal neurological deficit and seizures are reported as the most common <sup>2-3</sup>. </p><h4>Pathology</h4><p><em>Nocardia</em> spp. are aerobic gram-positive bacilli which are ubiquitous saprophytic organisms <sup>1-3</sup>. The infection is acquired primarily by inhalation of the bacillus from the environment, from where it can spread haematogenously to other organs and tissues <sup>1-2</sup>. In the CNS the infection manifests as <a href="/articles/pyogenic-meningitis">meningitis</a>, granuloma with giant cells or <a href="/articles/brain-abscess-1">cerebral abscesses</a> <sup>2</sup>. </p><p>Identification of <em>Nocardia</em> spp.<em> </em>in the clinical laboratory can be challenging: the organism may grow on cultures in intervals between 4 days to 2–4 weeks <sup>1</sup>.</p><h4>Radiographic features</h4><p>This infection has no specific features to aid in suggesting the diagnosis. It typically manifests as a <a href="/articles/brain-abscess-1">parenchymal abscess</a> in any part of the brain, though spinal cord abscesses and <a href="/articles/leptomeningitis">meningitis</a> have also been described <sup>1,2</sup>.</p><h4>Treatment and prognosis</h4><p>Medical and surgical opinions should be sought <sup>4,5</sup>. Empiric antibiotic treatment consists of trimethoprim-sulfamethoxazole plus either a carbapenem class antibiotic and/or amikacin <sup>4</sup>, while surgical management includes craniotomy or aspiration of abscesses <sup>4,5</sup>. Both craniotomy and aspiration have been found to be equally effective <sup>5</sup>.</p>